Svetlana Tikhanovskaya is discussing with European structures, the European Commission and the German government, the supply of vaccines and vaccinations for healthcare workers treating COVID-19 patients in Belarus. This was reported by the press service of Tikhanovskaya.
The vaccines will be sent to a number of European countries this week, some of which have already started COVID-19 vaccinations. Svetlana Tikhanovskaya believes that it is possible to organize a batch of vaccinations for Belarusian medics. An original vaccine can be supplied to Belarus from Germany, or produced in Lithuania or Poland in line with the recipe of the pharmaceutical company Pfizer.
Svetlana Tikhanovskaya discussed the issue of vaccine supplies to Belarus at a meeting with European Commissioner Oliver Varkhelyi. The current budget of the European Union, allocated to help Belarus, allows to organize these supplies. In this case, the consent of the Belarusian authorities is required. European officials are ready to negotiate this. The thing is that the Belarusian authorities are already buying a Russian vaccine.
Svetlana Tikhanovskaya, her press service notes, is discussing the supply of a European vaccine, which is produced in accordance with international standards. This will provide people and medical professionals with an opportunity to make their own choices.
“We need to help those who suffer the most from COVID-19 and irresponsible policies of Lukashenko and his officials regarding the pandemic. Every human life is important to us, every person who is at the forefront of the fight against the pandemic. If the state does not fulfill its obligations, then we are ready to take responsibility in our own hands. Therefore, I am discussing the issue of vaccines and those things that can save thousands of Belarusians,” said Tikhanovskaya.
Recall that earlier Lukashenko said that they government considers three ways of vaccination of Belarusians: to buy a ready-made vaccine from Russia in order to inoculate high-risk groups, to establish production of a Russian drug in the republic, or to develop ouwr own vaccine. All these options are planned to be discussed with the participation of stakeholders on 17 December.